Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 09 tags : Bioscience save search
Yield10 Bioscience Announces Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
YTEN | $0.252 -7.59% -8.21% 280K
|
Health Technology
|
| O: -4.32%
H: 36.57%
C: 21.9%
financial results bioscience results
QSAM Biosciences Announces Reverse Stock Split Effective March 10, 2022
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
QSAM | $7.78 -31.58% 12K
|
Manufacturing
| Email alert
Add to watchlist
bioscience
Prometheus Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Highlights Recent Corporate Progress
Published: 2022-03-09 (Crawled : 22:00) - biospace.com/
RXDX | $199.92 0.02% 1.9M
|
Professional, Scientific, and T...
|
| O: 2.08%
H: 9.62%
C: 8.89%
financial results report bioscience results
Twist Bioscience and Kriya Sign Agreement to Discover Novel Antibodies for Applications in Oncology Using Gene Therapy
Published: 2022-03-09 (Crawled : 19:00) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M
|
Health Technology
|
| O: 3.84%
H: 5.29%
C: 3.33%
application gene therapy therapy bioscience antibody
HARMONY BIOSCIENCES TO PARTICIPATE IN TWO INVESTOR CONFERENCES IN MARCH
Published: 2022-03-09 (Crawled : 13:30) - prnewswire.com
HRMY | $29.42 1.34% 1.33% 390K
|
Health Technology
|
| O: 4.19%
H: 3.46%
C: 2.39%
conference bioscience
Bright Minds Biosciences to Present at the Oppenheimer 32nd Annual Healthcare Conference
Published: 2022-03-09 (Crawled : 06:00) - brightmindsbio.com
DRUG | $1.25 -6.61% 11K
|
Manufacturing
|
| O: -0.58%
H: 2.94%
C: -1.76%
health thc conference bioscience
Caribou Biosciences to Present Preclinical Data on CB-011, an Immune-Cloaked Allogeneic Anti-BCMA CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-09 (Crawled : 02:00) - globenewswire.com
CRBU | $3.87 -1.02% -1.03% 1.7M
|
Health Technology
|
| O: 4.28%
H: 5.05%
C: 2.74%
cb-011 america car-t research cel preclinical therapy bioscience cancer t-cell pre-clinical
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.